Topic
diagnostics
7 stories related to this topic, newest first.
The Independentworld11 days ago
Five manufacturers advance rapid tests for Bundibugyo Ebola strain
A Geneva-based non-profit selected five companies to begin field trials of rapid antigen tests for the Bundibugyo Ebola virus. The move targets diagnostic delays in an outbreak that has infected 1,406 people and killed 438 in eastern Congo.
New York Postworld19 days ago
Health platform launches blood test screening for 130 conditions affecting women
A new service uses an annual blood draw to calculate risk probabilities for multiple conditions. The company plans to add a menstrual fluid test later this year.
link.springer.combusiness40 days ago
Mammogen Raises up to $30 Million Series A Led by Major U.S. Public Retirement System to Fund Breast Cancer Diagnostic Trial
Mammogen, a Newport Beach-based company, announced the institutional equity round on June 3, 2026. The funds will support its clinical program and commercialization of genTRU-breast.
manilatimes.netpolitics55 days ago
Rural Health Gaps Limit Early Alzheimer's Detection
Rural communities face shortages of dementia specialists and limited access to diagnostic testing. New blood-based tests cleared by the Food and Drug Administration last year may reduce those barriers if Medicare coverage expands.
Euronewsworld62 days ago
Roche's pTau217 Blood Test Receives CE Mark for Use in Europe
Roche announced Tuesday that its Elecsys pTau217 test, the first blood test designed to signal and rule out Alzheimer’s disease, has been cleared for use across the European Union. Developed with Eli Lilly and Company, the test aims to speed diagnosis for millions facing lengthy…
cnbc.comai67 days ago
Roche Agrees to Acquire PathAI for Up to $1.1 Billion
Roche has agreed to buy digital pathology company PathAI in a deal valued at up to $1.1 billion. The transaction comes as the pharmaceutical and diagnostics company expands its presence in artificial intelligence applications for pathology. Seekingalpha.com reported the agreement…
swissinfo.chscience81 days ago
Roche Reports Positive Trends in China and Improved Diagnostics Outlook for Second Half of 2026
A Roche executive indicated positive developments in the company's China operations. The diagnostics segment is expected to perform better in the second half of 2026 compared to the first. This outlook highlights ongoing progress in Roche's key markets and business segments.
FI